Comparison of Clevidipine and Nicardipine for Acute Blood Pressure Reduction in Patients With Stroke

Abstract

Objective:

The aim of this study was to determine whether clevidipine (CLEV) achieved faster blood pressure control compared to nicardipine (NIC) in patients presenting with either an acute ischemic stroke (AIS) or a spontaneous intracerebral hemorrhage (ICH).

Methods:

This was a retrospective, observational, cohort study conducted in patients with AIS or ICH admitted to the emergency department of a Comprehensive Stroke Center from November 2011 to June 2013 who received CLEV or NIC continuous infusion for acute blood pressure management.

Results:

The study included 210 patients: 70 in the CLEV group and 140 in the NIC group. There was no difference in mean time (standard deviation [SD]) from initiation of the infusion to goal systolic blood pressure (SBP), CLEV: 50 (83) minutes versus NIC: 74 (103) minutes, P = .101. Comparison of the 2 agents within diagnosis showed no difference. Hypotension developed in 5 (7.1%) CLEV patients versus 14 (10%) NIC patients (P = .003). There was no difference in the percentage change at 2 hours; CLEV: −20% (16%) versus NIC: −16% (16%), P = .058. Mean (SD) time to alteplase administration from admission was 56 (22) minutes in the CLEV group versus 59 (25) minutes in the NIC group (P = .684).

Conclusions:

There was no difference in the mean time from initiation of the infusion to the SBP goal between agents or in the secondary outcomes. Due to the lack of differences observed, each agent should be considered based on the patient care needs of the institution.

Keywords

hypertension acute ischemic stroke intracerebral hemorrhage antihypertensive nicardipine clevidipine

Get full access to this article

View all access options for this article.

References

Qureshi

Ezzeddine

Nasar

, et al. Prevalence of elevated blood pressure in 563704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25(1);32–38.

Qureshi

. The importance of acute hypertensive response in ICH. Stroke. 2013;44(suppl 1):S67–S69.

Dandani

Suzuki

Kelley

Reyes-Iglesias

Duncan

. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke. 1995;26(1):21–24.

Anderson

Huang

Arima

, et al. Effects of early intensive blood pressure lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Reduction in Acute Cerebral Hemorrhage Trial (INTERACT). Stroke. 2010;41(2):307–312.

Qureshi

Mohammad

Yahia

, et al. A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J Intensive Care Med. 2005;20(1):34–42.

Hemphill

Greenberg

Anderson

, et al; on behalf of the American Heart Association Stroke Council, Council on Cardiovascular and stroke Nursing, and Council on Clinical Cardiology. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–2060.

Qureshi

Palesch

Barsan

, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375(11):1033–1043.

Leonardi-Bee

Bath

Phillips

Sandercock

; IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke. 2002;33(5):1315–1320.

Willmot

Leonardi-Bee

Bath

. High blood pressure in acute stroke and subsequent outcome: a systemic review. Hypertension. 2004;43(1):18–24.

10.

Vemmos

Tsivgoulis

Spengos

, et al. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Int Med. 2004;255(2):257–265.

11.

Tommi

Toyoda

Nakashima

. Effects of hyperacute blood pressure and heart rate on stroke outcomes after intravenous tissue plasminogen activator. J Hypertens. 2011;29(10):1980–1987.

12.

Jauch

Saver

Adams

Jr , et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.

13.

Cardene [package insert]. Deerfield, IL: Baxter Healthcare Corporation; 2014.

14.

Cleviprex [package insert]. Graz, Austria: Fresenius Kabi Austria GmbH; 2013.

15.

R Core Team. R: a language and environment for statistical computing. Version 3.3.3. Vienna, Austria: R Foundation for Statistical Computing; 2016. https://www.R-project.org/.

16.

Levy

Mancao

Gitter

, et al. clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. Anesth Analg. 2007;105(4):918–925.

17.

Singla

Warltier

Gandhi

, et al; for the ESCAPE-2 Study Group. Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial. Anesth Analg. 2008;107(1):59–67.

18.

Aronson

Dyke

Stierer

, et al. The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium Nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg. 2008;107(4):1110–1121.

19.

Pollack

Varon

Garrison

Ebrahimi

Dunbar

Peacock

. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med. 2008;53(3):329–338.

20.

Graffagnino

Bergese

Love

, et al. Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: the ACCELERATE trial. Cerebrovasc Dis. 2013;36(3):173–180.

21.

Anderson

Heeley

Huang

, et al; for the INTERACT 2 Investigators. Rapid blood pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355–2365.

22.

Sullivan

Shaun

Hamilton

. Clevidipine vs. nicardipine for intensive blood pressure control in hemorrhagic stroke. Poster presented at: 44th Critical Care Congress; January 17-21, 2015; Phoenix, AZ.

23.

Finger

Kurszewski

Brophy

. Clevidipine versus nicardipine for acute blood pressure reduction in a neuroscience intensive care population. Neurocrit Care. 2017;(26):167–173.

24.

Brehaut

Roche

. Clevidipine outperforms other agents in emergent acute hypertension treatment in ischemic stroke pre-rt-PA. Poster presented at: American Heart Association/American Stroke Association 2015 International Stroke Conference and State-of-the-Science Stroke Nursing Symposium; February 11-13, 2015; Nashville, Tennessee.

25.

Qureshi

. Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med. 2010;38(2):637–648.